92 related articles for article (PubMed ID: 22421218)
1. Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition.
Jeon WK; Hong HY; Seo WC; Lim KH; Lee HY; Kim WJ; Song SY; Kim BC
Biochem Biophys Res Commun; 2012 Apr; 420(2):288-92. PubMed ID: 22421218
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells.
Kuroda H; Takeno M; Murakami S; Miyazawa N; Kaneko T; Ishigatsubo Y
Lung Cancer; 2010 Jan; 67(1):31-6. PubMed ID: 19375813
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin.
Kim HR; Kim S; Kim EJ; Park JH; Yang SH; Jeong ET; Park C; Youn MJ; So HS; Park R
Lung Cancer; 2008 Apr; 60(1):47-56. PubMed ID: 18006113
[TBL] [Abstract][Full Text] [Related]
4. Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway.
Hong S; Lee C; Kim SJ
Cancer Res; 2007 Oct; 67(19):9577-83. PubMed ID: 17909069
[TBL] [Abstract][Full Text] [Related]
5. Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation.
Jo EJ; Park SJ; Kim BC
Eur J Pharmacol; 2016 Oct; 788():321-327. PubMed ID: 27375080
[TBL] [Abstract][Full Text] [Related]
6. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
7. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
Wang M; Liu ZM; Li XC; Yao YT; Yin ZX
J Chemother; 2013 Jun; 25(3):162-9. PubMed ID: 23783141
[TBL] [Abstract][Full Text] [Related]
8. Elevated pressure, a novel cancer therapeutic tool for sensitizing cisplatin-mediated apoptosis in A549.
Oh S; Kim Y; Kim J; Kwon D; Lee E
Biochem Biophys Res Commun; 2010 Aug; 399(1):91-7. PubMed ID: 20643104
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of HO-1 promotes resistance of B-cell acute lymphocytic leukemia cells to HDAC4/5 inhibitor LMK-235 via the Smad7 pathway.
Guo Y; Fang Q; Ma D; Yu K; Cheng B; Tang S; Lu T; Wang W; Wang J
Life Sci; 2018 Aug; 207():386-394. PubMed ID: 29886060
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of heme oxygenase-1 enhances the chemosensitivity of laryngeal squamous cell cancer Hep-2 cells to cisplatin.
Lv X; Song DM; Niu YH; Wang BS
Apoptosis; 2016 Apr; 21(4):489-501. PubMed ID: 26801320
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells.
Lin CC; Chiang LL; Lin CH; Shih CH; Liao YT; Hsu MJ; Chen BC
Eur J Pharmacol; 2007 Apr; 560(2-3):101-9. PubMed ID: 17307160
[TBL] [Abstract][Full Text] [Related]
13. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
[TBL] [Abstract][Full Text] [Related]
14. Combined inhibition of Hsp90 and heme oxygenase-1 induces apoptosis and endoplasmic reticulum stress in melanoma.
Barbagallo I; Parenti R; Zappalà A; Vanella L; Tibullo D; Pepe F; Onni T; Li Volti G
Acta Histochem; 2015 Oct; 117(8):705-11. PubMed ID: 26493719
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
[TBL] [Abstract][Full Text] [Related]
16. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
17. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
18. Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin.
Lee MW; Kim DS; Min NY; Kim HT
Int J Cancer; 2008 May; 122(10):2380-4. PubMed ID: 18224693
[TBL] [Abstract][Full Text] [Related]
19. Heat Shock Protein 27, a Novel Regulator of Transforming Growth Factor β Induced Resistance to Cisplatin in A549 Cell.
Huang Z; Yang C; Sun S; Nan Y; Lang Z; Wang X; Zhao J; Liu Y
Pharmacology; 2017; 100(5-6):283-291. PubMed ID: 28848138
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
Arnold NB; Ketterer K; Kleeff J; Friess H; Büchler MW; Korc M
Cancer Res; 2004 May; 64(10):3599-606. PubMed ID: 15150118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
